Tambac, Prince Jay V.

HRN: 26-06-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/16/2024
12/23/2024
IV
125mg
Q6H
PCAP C
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: